tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex
A plain-language introduction is being prepared for this study. Open it to read the original description, who can join and how to contact the team.
Testing a treatment or activity · Study reference: NCT07240272
The registry title is shown while an English plain-language introduction is prepared. Read the original details below ↓
This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.
Open the official registry record ↗Follow this study
Completed; watching for results
- Start (reported actual date)
- 2023-08-01
- Main measurements finished (reported actual date)
- 2025-05-01
- Study finished (reported actual date)
- 2025-08-01
Planned dates can move. A study finishing does not tell us when a paper will be published.
No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.
Changes we have recorded
- 2026-10-11 — completed
These are dates we observed a change, not necessarily the dates it happened.
Papers connected to this study
Theta tACS Over the Medial Frontal Cortex Modulates Executive Function in Parkinson's Disease: A Randomized, Sham-Controlled Study.
Listed by the registry as research derived from the study · 2026
Participation rules recorded for this study
Ages 35 years to 80 years · Also accepts healthy volunteers
These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.
Read all the rules for taking part
Sex eligibility reported by registry: all
Full study name & original research details
Official study title
Modulation of Executive Functions and Speech in Parkinson's Disease by Theta tACS Targeted at the Medial Frontal Cortex
Short title used by the registry
tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex
Original description
Conditions reported: Parkinson Disease
Registry records for this study
Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.
- ClinicalTrials.gov · NCT07240272 ↗ — COMPLETED; checked 2026-10-11
- ClinicalTrials.gov · NCT07240272 ↗ — Not recruiting; WHO ICTRP processed 2025-11-24; checked 2026-10-11
- Study type
- Interventional
- Interventions
- 6Hz-tACS; Sham-tACS
- Phases
- NA
- Sponsor
- Ke Dong, MD
- Start date reported by registry
- 2023-08-01 (actual)
Registry updated: 2025-11-20 · Status last verified by the registry submitter: 2025-09
Registry records retrieved 2026-10-11 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.
Contact the research team
Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.
No central contact is listed. Check the location contacts or the official registry record.
Study locations
Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.
Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Status not reportedFacility not reported
China
Status not reportedThe original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.